Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Progyny (PGNY)
NASDAQ:PGNY
Holding PGNY?
Track your performance easily
PGNY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$13.39 - $42.08
Previous Close$13.67
Volume1.42M
Average Volume (3M)2.26M
Market Cap
$1.16B
Enterprise Value$944.95M
Total Cash (Recent Filing)$235.72M
Total Debt (Recent Filing)$16.63M
Price to Earnings (P/E)23.5
Beta1.42
Next Earnings
Mar 03, 2025EPS Estimate
$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.58
Shares Outstanding85,153,267
10 Day Avg. Volume2,076,002
30 Day Avg. Volume2,263,861
Standard Deviation0.17
R-Squared0.20
Alpha-0.00610
Financial Highlights & Ratios
Price to Book (P/B)2.74
Price to Sales (P/S)1.02
Price to Cash Flow (P/CF)6.50
P/FCF Ratio6.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.83
Enterprise Value/Gross Profit3.96
Enterprise Value/Ebitda16.30
Forecast
1Y Price Target
$18.86Price Target Upside34.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Progyny News
Bulls Say, Bears Say
Bulls Say
Client Retention And SatisfactionClient retention remains high at 99%, with 30% of the book increasing the program offering, affirming customer satisfaction and loyalty.
Market LeadershipProgyny won all of its jumbo selling season opportunities, countering the narrative that the company is losing market share, and solidifying its leadership in the growing fertility market.
New Client AcquisitionProgyny's successful selling season added more than 80 clients and 1.1M covered lives, indicating strong demand for their services.
Bears Say
Financial PerformanceProgyny reported disappointing results with both revenue and adjusted EBITDA reduced, leading to a downgraded rating from Buy to Hold by analysts.
Growth ConcernsThe recent loss of Progyny's largest contract in Amazon raises concerns about the company's growth trends in 2025.
Market CompetitionProgyny is facing several headwinds from competitors like Maven and Carrot, which are becoming more aggressive in the market.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PGNY FAQ
What was Progyny’s price range in the past 12 months?
Progyny lowest stock price was $13.39 and its highest was $42.08 in the past 12 months.
What is Progyny’s market cap?
Currently, no data Available
When is Progyny’s upcoming earnings report date?
Progyny’s upcoming earnings report date is Mar 03, 2025 which is in 102 days.
How were Progyny’s earnings last quarter?
Progyny released its earnings results on Nov 12, 2024. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.143 by -$0.033.
Is Progyny overvalued?
According to Wall Street analysts Progyny’s price is currently Undervalued.
Does Progyny pay dividends?
Progyny does not currently pay dividends.
What is Progyny’s EPS estimate?
Progyny’s EPS estimate is $0.1.
How many shares outstanding does Progyny have?
Progyny has 85,153,270 shares outstanding.
What happened to Progyny’s price movement after its last earnings report?
Progyny reported an EPS of $0.11 in its last earnings report, missing expectations of $0.143. Following the earnings report the stock price went down -19.092%.
Which hedge fund is a major shareholder of Progyny?
Among the largest hedge funds holding Progyny’s share is Farallon Capital Management, L.L.C.. It holds Progyny’s shares valued at 22M.
---
Progyny Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.86 (34.91% Upside)
$18.86 (34.91% Upside)
Blogger Sentiment
Bullish
PGNY Sentiment 75%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 42.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.9%
Last 30 Days ▼ 3.2%
Last 30 Days ▼ 3.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.54%
12-Months-Change
Fundamentals
Return on Equity
12.05%
Trailing 12-Months
Asset Growth
-9.16%
Trailing 12-Months
Company Description
Progyny
Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.
---
PGNY Earnings Call
Q3 2024
0:00 / 0:00
---
PGNY Stock 12 Month Forecast
Average Price Target
$18.86
▲(34.91% Upside)
Technical Analysis
Best Analysts Covering PGNY
1 Year
1 Year Success Rate
2/16 ratings generated profit
1 Year Average Return
-27.98%
reiterated a buy rating 9 days ago
Copying Anne Samuel's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -27.98% per trade.
---